Top Markets
#1 MowCat MowCat +48.88%
#2 Bermuda Shorts Bermuda Shorts +25.27%
#3 Velvet Velvet +25.14%
#4 Derive Derive +21.09%
#5 Audiera Audiera +20.34%
#6 Biconomy Biconomy +18.91%
#7 aPriori aPriori +18.15%
#8 Quack AI Quack AI +17.54%
#9 Geodnet Geodnet +12.27%
#10 Perle Perle +10.44%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Kane Biotech Inc. Kane Biotech Inc.

Kane Biotech Inc.

KNE
Rank in Stocks #35058
Headquartered in Winnipeg, Canada, Kane Biotech Inc. is a biotechnology firm... Headquartered in Winnipeg, Canada, Kane Biotech Inc. is a biotechnology firm established in 2001, focusing on the research, development, and global commercialization of innovative technologies and products engineered to prevent and remove microbial biofilms. The company's diverse portfolio features pet dental hygiene solutions marketed as StrixNB and bluestem, alongside DispersinB for both animal and human wound care. They also provide Alosera brand shampoos for dogs, cats, and horses, and Aledex for medical device coatings. Additional offerings include DermaKB scalp care products, Coactiv+ wound care items, and other specialized products under the goldstem, silkstem, and DermaKB Biofilm brand names.
Share Price
$0.02201811
Last synced: 2026-08-14
Market Cap
$4.51M
Change (1 day)
0.00%
Change (1 year)
-32.38%
Country
CA
Trade Kane Biotech Inc. (KNE)

Category

Healthcare
Earnings for Kane Biotech Inc. (KNE)
Earnings in 2026 TTM: 0
According to Kane Biotech Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Kane Biotech Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE